TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14754 · May 27

#rust#caldav#carddav#imap#jmap#mail#pop3#rust#server#smtp#webdav Stalwart is a secure, fast, and scalable open-source mail and collaboration server supporting all major email protocols (IMAP, SMTP, JMAP, POP3) plus calendar, contacts, and file sharing. It offers strong built-in spam and phishing protection, advanced message authentication (DMARC, DKIM, SPF), and flexible storage options. Designed for high availability and fault tolerance, it can scale from small setups to thousands of nodes without complex proxies. Its web-based admin interface and automation tools simplify management. Using Stalwart helps you control your email securely, improve collaboration, and reduce reliance on big tech, making your communication more private and reliable. https://github.com/stalwartlabs/stalwart

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment